Employees Retirement System of Texas’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.09M | Buy |
+9,474
| New | +$3.09M | 0.03% | 215 |
|
|
2025
Q1 | – | Sell |
-8,403
| Closed | -$1.98M | – | 269 |
|
|
2024
Q4 | $1.98M | Hold |
8,403
| – | – | 0.02% | 234 |
|
|
2024
Q3 | $2.31M | Buy |
8,403
+686
| +9% | +$189K | 0.02% | 240 |
|
|
2024
Q2 | $1.88M | Hold |
7,717
| – | – | 0.02% | 233 |
|
|
2024
Q1 | $1.15M | Buy |
7,717
+3,956
| +105% | +$591K | 0.01% | 268 |
|
|
2023
Q4 | $720K | Buy |
+3,761
| New | +$720K | 0.01% | 287 |
|
|
2022
Q3 | – | Sell |
-11,018
| Closed | -$1.61M | – | 364 |
|
|
2022
Q2 | $1.61M | Hold |
11,018
| – | – | 0.02% | 562 |
|
|
2022
Q1 | $1.8M | Hold |
11,018
| – | – | 0.02% | 577 |
|
|
2021
Q4 | $1.87M | Hold |
11,018
| – | – | 0.02% | 564 |
|
|
2021
Q3 | $2.08M | Hold |
11,018
| – | – | 0.02% | 561 |
|
|
2021
Q2 | $1.87M | Hold |
11,018
| – | – | 0.02% | 586 |
|
|
2021
Q1 | $1.56M | Hold |
11,018
| – | – | 0.02% | 628 |
|
|
2020
Q4 | $1.43M | Hold |
11,018
| – | – | 0.02% | 545 |
|
|
2020
Q3 | $1.6M | Hold |
11,018
| – | – | 0.02% | 541 |
|
|
2020
Q2 | $1.63M | Hold |
11,018
| – | – | 0.02% | 523 |
|
|
2020
Q1 | $1.2M | Hold |
11,018
| – | – | 0.02% | 541 |
|
|
2019
Q4 | $1.27M | Hold |
11,018
| – | – | 0.02% | 649 |
|
|
2019
Q3 | $886K | Buy |
+11,018
| New | +$886K | 0.01% | 743 |
|